T o overcome problems associated with fat grafting, such as unpredictable clinical results and a low rate of graft survival, many innovative efforts and refinements of surgical techniques have been reported. For example, condensation of living tissue and removal of unnecessary components have been performed by centrifugation, filtration, or gravity sedimentation 1, 2 Fat Grafts Supplemented with Adipose-Derived Stromal Cells in the Rehabilitation of Patients with Craniofacial Microsomia Supplemental digital content is available for this article. Direct URL citations appear in the text; simply type the URL address into any Web browser to access this content. Clickable links to the material are provided in the HTML text of this article on the Journal's Web site (www.PRSJournal.com). skin envelope 3, 4 ; and a recent experimental study suggested that repeated local injections of erythropoietin may enhance retention of grafted fat. 5 Based on the finding that aspirated fat tissue contains a much smaller number of adiposederived stromal cells compared with intact tissue [6] [7] [8] [9] and that these cells play pivotal roles in the adipose tissue remodeling after lipoinjection, [10] [11] [12] the supplementation of fat grafts with stromal vascular fraction isolated from the adipose portion of liposuction aspirates has been proposed as a method of compensating its relative deficiency of adiposederived stromal cells. 13 In the literature there are at least three experimental studies demonstrating that supplementation of progenitor cells enhances the volume or weight of surviving adipose tissue, 6, [13] [14] [15] [16] and first reports of its clinical use suggest that this approach may be feasible and effective for softtissue augmentation on the breast, face, hip, and hand. 12, [17] [18] [19] [20] [21] [22] However, considering that these studies represent level IV evidence (which corresponds to the publication of case series), 23 there is a lack of randomized, controlled clinical trials comparing this method to current standard techniques. 24 Thus, this study aimed to fill this gap by investigating whether a faster protocol for isolation of adiposederived stromal cells and their use in combination with fat tissue improve the long-term retention of the grafts in patients with craniofacial microsomia.
PATIENTS AND METHODS

Study Design
A prospective, randomized, controlled, observerand patient-blinded, single-center surgical trial with two parallel comparison groups was carried out. The study was approved by the institutional ethical committee (CAPPesq 1069/08).
Trial Population and Eligibility Criteria
From January of 2010 to June of 2011, every patient with craniofacial microsomia who presented at our department was assessed for enrollment in the study. Inclusion criteria were the presence of unilateral deformity; phenotype M0, M1 or M2, and S1 or S2 according to the Orbit, Mandible, Ear, Nerve, and Soft Tissue-Plus classification 25, 26 ; and age between 10 and 35 years. Excluded were patients with previous facial softtissue surgery, patients with absence of lower abdomen fat donor site, and those who refused to participate in the study. Informed consent was obtained from each subject at study entry.
Randomization and Masking
Patients were randomized by a computer-generated number table (http://www.randomization. com), which was used to assign patients to one of two groups. Patients, data analysts, and the trial statistician were blinded for the trial intervention.
Interventions
Patients underwent fat grafting with either supplementation of adipose-derived stromal cells (experimental group) or without supplementation of adipose-derived stromal cells (control group).
Surgical Technique
For both groups, fat harvest, preparation, and application were performed in a standardized manner in accordance with Coleman's recommendations 1 by the same plastic surgeon. Briefly, fat was harvested from the lower abdomen using manual suction with a 10-cc syringe and a 2.5-mm blunt cannula. Syringe-assisted lipoaspirate was centrifuged at 700 g for 3 minutes (Technofat, São Paulo, Brazil). Following centrifugation, the blood/tumescent fraction was drained and the oil was removed.
For the control group, the resulting fat layer was used for grafting ( Fig. 1) . For the experimental group, half of this volume was used for isolation of adipose-derived stromal cells, which allowed supplementation of the other half with adipose progenitor cells at a 1:1 ratio (Fig. 2) .
The adipose portion of liposuction aspirates was digested with 0.15% collagenase type IA (Sigma-Aldrich, St. Louis, Mo.) for 20 minutes on a shaker at 37°C. Mature adipocytes and connective tissue were separated from the stromal vascular fraction by centrifugation at 176 g for 5 minutes, and pellets were resuspended in 1 cc of hypotonic water. Freshly isolated adipose-derived stromal cells were added to the graft material. After gentle mixing and waiting for 10 minutes for cell adherence to the aspirated fat, the cell-supplemented fat was then transferred into 1-cc syringes for injection.
For both groups, multiple access sites and a fan-like pattern technique using 1.4-mm and 1.8-mm blunt cannulas were used to transfer small aliquots of fat into various depths of the soft tissue. Quantity of transplanted adipose tissue was determined by attempting to obtain symmetry with the unaffected side without any overcorrection.
Clinical Assessment
Preoperative variables included age, sex, and body mass index; and intraoperative variables were surgical time, volume of fat harvested, and the ratio between the quantity of fat harvested and the quantity of fat obtained after centrifugation. Postoperatively, patients were asked to return for follow-up appointments at weeks 1, 2, and 4 and at months 3 and 6; at each follow-up visit, surgical complications were documented and patients were photographed.
Cellular Assessment
Immediately after the surgical procedure, the number of viable cells isolated before and after the supplementation of the grafts was counted using the trypan blue dye exclusion assay in a Neubauer chamber using a Nikon Eclipse TS100 light microscope (Nikon Instruments, Inc., Melville, N.Y.). Next, immunophenotype characterization of cell populations on passage 1 was performed by flow cytometric analysis with the anti-human antibodies CD29, CD31, CD45, CD90, CD73, and CD105 (Becton, Dickinson and Company, Franklin Lakes, N.J.) in a Guava EasyCyte flow cytometer running the Guava Express Plus software (Guava Technologies, Hayward, Calif.). Adipose-derived stem cell cultures were performed according to Aguena et al. 27 
Radiographic Assessment
Computed tomographic scans were obtained preoperatively and 6 months postoperatively for volumetric and soft-tissue thickness measurements of both hemifaces using Osirix MD software (Pixmeo, Bernex, Switzerland). Volumetric augmentation was noted for each patient by comparing the difference between volumes of affected and unaffected hemifaces in the preoperative and postoperative periods, which was considered the 
Results Classification
Based on the percentage of fat graft survival regarding grafted volume, results were classified as follows: excellent, 75 to 100 percent; good, 50 to 75 percent; and unsatisfactory, 0 to 50 percent. Fat graft preparation for the control group. After centrifugation, the syringe-assisted lipoaspirate is separated based on its density. The oil fraction at the top can be wicked away, and the bloody fraction at the bottom can be drained. The resulting fat layer is used for grafting.
Power Analysis and Statistics
Statistical and inferential analyses were performed by means of SPSS statistics software version 17 (SPSS, Inc., Chicago, Ill.). The assumptions of normal distribution in each group and homogeneity of variances between groups were evaluated, respectively, with the Shapiro-Wilk and Levene tests. In all inferential analyses, a type I (α) error probability at 0.05 was considered. Quantitative data were analyzed using a one-way analysis of variance for linear mixed-effect models (analysis of variance) or a t test. The Fisher's exact test and the likelihood ratio test were used for categorical data. Relative risk and its variables were calculated as an instrument of association between independent variables (type of intervention) and the dependent one (type of result). To identify differences between the two parallel comparison groups and based on a previous pilot study (80 percent power, α = 0.05), it was calculated through Minitab release 14.12.0 statistical software (Minitab, Inc., State College, Pa.) that 18 patients needed to be recruited.
RESULTS
Study Population and Surgical Variables
A total of 29 patients were enrolled, of whom 18 could be included and randomized. During follow-up, two subjects from the control group dropped out (did not answer telephone calls or return for follow-up appointments), and two patients from the experimental group were excluded because of inadequacy of computed tomographic scans. Both groups were comparable in terms of age, sex, and body mass index (Table 1) .
For the control group, the mean surgical time was 80 minutes; for the experimental group, there was an average increase of 45 minutes (p < 0.001) ( Table 2 ). With regard to the volume of fat harvested, the experimental group presented 50 percent more lipoaspirate, but in terms of percentage yield of fat obtained after centrifugation there was no significant difference between the experimental and control groups (p = 0.11) ( Table 2 ). In the early postoperative period, both groups presented discrete swelling that resolved uneventfully, and thereafter there were no cases of surgical complications.
Characterization of Adipose-Derived Stromal Cells
A great variability in the absolute number of viable cells was found between individuals, but without correlation with age, sex, or body mass index (Table 3) . For the experimental group, before the supplementation of adipose-derived stromal cells, the average number counted was similar to the control group (p = 0.98), but after the supplementation process, there was an average increase of 73 percent for these values (p = 0.015) ( Table 3) . Based on the criteria of the International Society for Cellular Therapy, cells showed positive staining for mesenchymal (CD73, CD90, and CD105) and adhesion (CD29) markers and negative staining for hematopoietic (CD45) and endothelial (CD31) markers (Table 4) .
Radiographic Parameters
Preoperatively, both groups had similar softtissue deficiencies (p = 0.41), but postoperatively, patients from the experimental group had a statistically significantly better retention volume than those from the control group (p = 0.008) ( Table 5) .
For the control group, the percentages of fat graft survival regarding symmetry and grafted volume were 51 and 54 percent, respectively; for the experimental group, these indexes were 84 and 88 percent, respectively (p = 0.003 and p = 0.002) ( Table 5 ). Regarding fat graft survival per facial anatomical region, the experimental group had statistically significantly better postoperative symmetry scores for the lateral canthus, zygomatic process, and mental tubercle than did the control group (p = 0.002 versus p = 0.58, p = 0.01 versus p = 0.18, and p = 0.04 versus p = 0.59, respectively); only for angle of mandible did both groups show significant improvement postoperatively (p = 0.001 versus p = 0.009) ( Table 6 and Figs. 3 through 6 ).
Relative Risk and Its Variables
Results classification based on percentage of fat graft survival regarding grafted volume showed unsatisfactory results for 57.1 percent of the control group and a predominance of excellent results for the experimental group (experimental (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) group: excellent results, 7; control group: excellent, 1; good, 2; unsatisfactory, 4). Through the calculation of relative risk and its variables, it was observed that the experimental group would be seven times as likely as the control group to obtain an excellent result, and an excellent result was attributable to the intervention of supplementation of adipose-derived stromal cells in 85 percent (p = 0.005) ( Table 7) .
DISCUSSION
This study is the first prospective, randomized, controlled, observer-and patient-blinded trial to objectively compare results of structural fat grafting with and without supplementation of adiposederived stromal cells. Patients with craniofacial microsomia were chosen because this condition is usually unilateral. Through the use of data from the contralaterally preserved healthy hemiface, we 
Table 5. Descriptive Statistics of Volumetric Variables
Control Group Experimental Group p
Preoperative difference between volumes of affected and unaffected hemifaces, cc Mean ± SD 32.1 ± 9. were able to obtain control values for estimating facial volume and to evaluating volume changes on the affected side. Moreover, this study is the first to correlate the cellular yield of a protocol for isolation of adipose-derived stromal cells with clinical results and demographic variables. For correction of soft-tissue deficiency in patients with craniofacial microsomia, a microvascular free tissue transfer has been used widely. [28] [29] [30] [31] However, although free tissue transfer is effective, it is not without risk and morbidity in this patient population, 32 and because of this, serial fat grafting has recently been proposed as an alternative for earlier soft-tissue improvement. 33 In a volumetric outcome comparison of patients who underwent serial autologous fat grafting or microvascular free flap surgery, it was reported that although the mean number of procedures needed to obtain symmetry was less for the microvascular free flap group compared with the fat-grafting group (2.2 versus 4.3), the combined surgical time was greater for the microvascular free flap group (490 versus 280 minutes). 33 In this study, for patients undergoing structural fat grafting with supplementation of adipose-derived stromal cells, symmetry scores were high, with only a single procedure and a mean surgical time of 125 minutes.
Because adipose-derived stromal cells contain multiple types of stem and regenerative cells, a cooperative interaction among these cells and the factors that they produce may allow these cells to enhance graft survival and quality by simultaneously targeting multiple mechanisms, including increasing revascularization, reducing apoptosis, and promoting preadipocyte differentiation. 15 Furthermore, instead of using autologous cultured cells, there are practical reasons for our choice to evaluate the freshly isolated cell population. First, using fresh isolated cells is consistent with a smooth clinical workflow, where the patient can undergo liposuction and receive a cell-supplemented fat graft in the same visit. By contrast, use of autologous cultured cells would require a twostage procedure: the first to harvest tissue from which the cells needed to initiate the cultures are procured, and a delay of a few weeks during which these cells are cultured before the second procedure, in which a second liposuction procedure is performed to obtain the graft matrix and the cellsupplemented fat graft subsequently prepared and implanted. Significant safety considerations with cultured cells are also important because extensive cell culture can lead to the development of chromosomal abnormalities and transformation of cells, [34] [35] [36] properties that are not seen in the freshly isolated population. In addition, cell culture for clinical use requires application of expensive reagents and good manufacturing practices infrastructure, and this motivation is to understandably generate an adequate cell dose. However, as shown by several authors, it does not appear to be necessary with adipose tissue, where the stem cell frequency is approximately 2500-fold higher. 37 In this study, by counting the number of viable cells isolated before and after the supplementation of the grafts, an average increase of 73 percent for these values was observed, and by immunophenotype characterization of cells, positive staining for mesenchymal and adhesion markers was detected, which confirms the effectiveness of this strategy for isolation and supplementation of adipose-derived stromal cells.
However, in spite of a statistically significant augmentation of progenitor cells in the grafts (p = 0.015), we did not find the intuitive twofold higher number of cells that would be expected with the supplementation process at the 1:1 ratio. This could be attributable to the 20-minute protocol used for enzymatic digestion; however, further studies comparing stromal vascular fraction generation with different collagenase concentrations and digestion times are still required to elucidate which is the optimized method. In the literature, Matsumoto et al. described a 0.075% collagenase digestion for 30 minutes, 6 Tiryaki et al. reported an incubation period of 40 to 60 minutes, 21 and Faustini et al. suggested a collagenase concentration of 0.2% and a digestion time of 1 hour as the best operating conditions. 38 However, even for the comparative study of Faustini et al. that evaluated five different collagenase concentrations ranging from 0.05 to 0.2%, 38 there are limitations with regard to different incubation times that ranged from 1 to 12 hours, but not below it.
In this study, striking differences in clinical results could be appreciated because of supplementation of adipose-derived stromal cells; however, in agreement with the findings of Padoin et al., a great variability in the absolute number of these cells was detected between individuals, and age, sex, and body mass index of the donor seemed not to influence this cellular yield. 39 Because we previously demonstrated a significant higher concentration of nucleated cells and an enriched subpopulation of cells of mesenchymal origin in samples from the lower abdomen when compared with others, 27 we did not consider any other donor sites. Although no consensus exists regarding the best technique and the longevity of results, the Coleman technique has gained widespread clinical application and has been adopted by many plastic surgeons. 40 Thus, to understand how the supplementation of adipose-derived stromal cells significantly enhanced graft survival, we have focused our attention on the comparison of this technique with and without the cellular enrichment.
Results of fat-grafting procedures typically are assessed by observation, examination with palpation, and photographs, but currently, more objective methods including laser scanners, threedimensional photography, and computed tomographic imaging studies are available for assessing outcomes. 41 Because three-dimensional computed tomography with volume rendering enables measurement of distance, area, and volume, 42, 43 and multiplanar three-dimensional reconstruction reduces the number of artifacts and superimposition of structures (both of which can hinder 44 we used three-dimensional computed tomography for blinded and comparative evaluation of facial volume during preoperative and 6-month postoperative periods. In contrast to satisfactory outcomes observed in patients who underwent structural fat grafting with supplementation of adipose-derived stromal cells, such results were not achieved in patients who received conventional microfat grafting alone, for whom resorption rates were at least threefold higher. In agreement with these results, fat graft survival per facial anatomical region were also significantly better for patients receiving the cellular enrichment, even in areas such as the temporal region, considered one of the poorest recipient sites. 45 Many investigators are concerned about the potential complications of stem cell therapy. We therefore kept monitoring clinical parameters, and thus far (for up to 1 year) no complications or hazards associated with this new therapy modality have been detected in either donor or recipient sites.
At our institution, the mean additional cost for patients receiving the supplementation of adipose-derived stromal cells, including facility, equipment, and consumables, was $180, but we believe this increased cost is well offset by the cost reduction from the decreased number of operations necessary to obtain satisfactory results.
Our study has the limitation of a substantial dropout rate, with fewer patients included than intended, but with the number of patients balanced between both treatment groups. Whereas we think this has not influenced the results, this is of course not certain. Another possible limitation is that the nature of treatment made it impossible to blind the surgical team. To overcome this drawback, we have blinded patients, data analysts, and the trial statistician.
Although longer follow-up is still required, our results showed that this strategy for isolation and supplementation of adipose-derived stromal cells enhanced fat survival in a relevant clinical application, being effective, safe, and superior to conventional lipoinjection for facial recontouring in patients with craniofacial microsomia. Additional randomized controlled trials are necessary to substantiate the evidence for this strategy for increasing fat graft survival in various clinical circumstances. 
PATIENT CONSENT
Patients or parents or guardians provided written consent for use of the patients images. 
